Cargando…
Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean Region: it takes a village…
Congenital adrenal hyperplasia (CAH), if untreated, carries high morbidity and mortality. A higher incidence of CAH is expected in countries where consanguinity is common, such as in the countries of the WHO Eastern Mediterranean Region (EMRO). CAH is managed through lifelong treatment with fludroco...
Autores principales: | Rowlands, Amanda, Deeb, Asma, Ladjouze, Asmahane, Hamza, Rasha T, Musa, Salwa A, Raza, Jamal, Jennane, Farida, Abu-Libdeh, Abdulsalam, Chanoine, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532553/ https://www.ncbi.nlm.nih.gov/pubmed/34675026 http://dx.doi.org/10.1136/bmjgh-2021-007195 |
Ejemplares similares
-
Fludrocortisone/hydrocortisone: Lack of efficacy: 2 case reports
Publicado: (2021) -
Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta‐analysis
por: Yamamoto, Ryo, et al.
Publicado: (2020) -
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021) -
Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010) -
Effects of low-dose hydrocortisone and hydrocortisone plus fludrocortisone in adults with septic shock: a protocol for a systematic review and meta-analysis of individual participant data
por: Annane, Djillali, et al.
Publicado: (2020)